Takotsubo syndrome (TTS) has been a recognized clinical entity for 31 years, since its first
description in 1990. TTS is now routinely diagnosed in patients who present with acute chest …

This is the first part of a scientific statement from the Heart Failure Association (HFA) of the
European Society of Cardiology focused upon the pathophysiology of Takotsubo syndrome …

Takotsubo cardiomyopathy (TTS) has become a recognised clinical entity since the
Japanese scientist Sato first described it in 1990. Despite an increasing number of …

Takotsubo cardiomyopathy (TCM), characterized by reversible ventricular dysfunction, has
similar mortality to acute coronary syndrome. With the growing interest in the diagnosis of …

Background Atrial fibrillation (AF) is a major risk factor for mortality. The prevalence, clinical
correlates, and prognostic impact of AF in Takotsubo syndrome (TTS) have not yet been …

Currently, there are 2 proposed causes of acute left ventricular ballooning. The first is the
most cited hypothesis that ballooning is caused by direct catecholamine toxicity on …

Takotsubo cardiomyopathy or stress cardiomyopathy (SCM), was first described in 1990 and
initially, it was thought to be only associated with short-term complications and mortality with …

Aims Recent insights have emphasized the importance of myocardial and systemic
inflammation in Takotsubo syndrome (TTS). In a large registry of unselected patients, we …

A unique clinical feature of Takotsubo syndrome (TTS) is the stress trigger factor. Different
types of triggers exist, generally divided into emotional and physical stressor. The aim was to …

Takotsubo syndrome was featured in various sessions and posters at the recent Heart
Failure Congress and World Congress on Acute Heart Failure 2019 held in Athens. The …